182 related articles for article (PubMed ID: 36238550)
1. Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring.
Guo HL; Zhao YT; Wang WJ; Dong N; Hu YH; Zhang YY; Chen F; Zhou L; Li T
Front Pharmacol; 2022; 13():941182. PubMed ID: 36238550
[TBL] [Abstract][Full Text] [Related]
2. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.
Toksvang LN; Lee SHR; Yang JJ; Schmiegelow K
Leukemia; 2022 Jul; 36(7):1749-1758. PubMed ID: 35654820
[TBL] [Abstract][Full Text] [Related]
3. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
4. Review article: thiopurines in inflammatory bowel disease.
Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
Kakuta Y; Kinouchi Y; Shimosegawa T
J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
[TBL] [Abstract][Full Text] [Related]
6. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
7. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
8. The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review.
Ribeiro AC; Gerheim PSAS; Chebli JMF; Nascimento JWL; de Faria Pinto P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959208
[TBL] [Abstract][Full Text] [Related]
9. Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G; Franca R; Verzegnassi F; Londero M; Rabusin M; Decorti G
Front Genet; 2012; 3():309. PubMed ID: 23335936
[TBL] [Abstract][Full Text] [Related]
10. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Thioguanine in DNA Using Liquid Chromatography-Tandem Mass Spectrometry for Routine Thiopurine Drug Monitoring in Patients With Pediatric Acute Lymphoblastic Leukemia.
Choi R; Chun MR; Park J; Lee JW; Ju HY; Cho HW; Hyun JK; Koo HH; Yi ES; Lee SY
Ann Lab Med; 2021 Mar; 41(2):145-154. PubMed ID: 33063676
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
14. Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.
Roberts RL; Gearry RB; Kennedy MA; Barclay ML
Per Med; 2008 May; 5(3):233-248. PubMed ID: 29783500
[TBL] [Abstract][Full Text] [Related]
15. Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.
Yang T; Chao K; Zhu X; Wang XD; Chan S; Guan YP; Mao J; Li P; Guan SX; Xie W; Gao X; Huang M
World J Gastroenterol; 2024 Mar; 30(12):1751-1763. PubMed ID: 38617736
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients.
Khaeso K; Nakkam N; Komwilaisak P; Wongmast P; Chainansamit SO; Dornsena A; Kanjanawart S; Vannaprasaht S; Tassaneeyakul W
J Pediatr Genet; 2021 Mar; 10(1):29-34. PubMed ID: 33552635
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics.
Chang JY; Cheon JH
Dig Dis Sci; 2019 Sep; 64(9):2395-2403. PubMed ID: 31290039
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of
Nishii R; Moriyama T; Janke LJ; Yang W; Suiter CC; Lin TN; Li L; Kihira K; Toyoda H; Hofmann U; Schwab M; Takagi M; Morio T; Manabe A; Kham S; Jiang N; Rabin KR; Kato M; Koh K; Yeoh AE; Hori H; Yang JJ
Blood; 2018 May; 131(22):2466-2474. PubMed ID: 29572377
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]